GlassScriptPhysician profile
Kimberly Dawn Harrison
NPI 1447887997
$716.75
in general payments reported to CMS, 2019-2025
15 companies · $201 in 2025
The $201 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $111 · 2024: $405 · 2025: $201.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $717.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $716.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $236.02 | 2023-2025 | Mounjaro, Trulicity, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $112.31 | 2023-2025 | Jardiance |
| Exact Sciences Corporation | $77.82 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Pfizer INC. | $46.77 | 2023-2024 | |
| Novo Nordisk INC | $44.54 | 2023-2025 | Ozempic, Rybelsus, Tresiba |
| Collegium Pharmaceutical, INC. | $40.68 | 2025 | Jornay Pm |
| Dexcom, INC. | $23.91 | 2024 | Dexcom G6 Transmitter |
| Phathom Pharmaceuticals, INC. | $22.69 | 2024 | Voquezna |
| Merck Sharp & Dohme LLC | $18.37 | 2024 | Vaxneuvance, Gardasil, Capvaxive |
| Alk-Abello, INC | $17.58 | 2023 | Ragwitek, Grastek, Odactra |
| Amgen INC. | $17.36 | 2024 | Otezla, Repatha |
| Glaxosmithkline, LLC. | $16.63 | 2024 | Trelegy Ellipta |
| Sanofi-Aventis U.S. LLC | $14.65 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $13.78 | 2024 | Airsupra |
| Supernus Pharmaceuticals, INC. | $13.64 | 2024 | Qelbree |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Harrison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.